Advances in understanding the pathogenesis of primary familial and congenital polycythaemia

Lily J. Huang, Yu Min Shen, Gamze B. Bulut

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Primary familial and congenital polycythemia (PFCP) is an autosomal-dominant proliferative disorder characterized by erythrocytosis and hypersensitivity of erythroid progenitors to erythropoietin (Epo). Several lines of evidence suggest a causal role of truncated erythropoietin receptor (EpoR) in this disease. In this review, we discuss PFCP in the context of erythrocytosis and EpoR signalling. We focus on recent studies describing mechanisms underlying Epo-dependent EpoR down-regulation. One mechanism depends on internalization mediated through the p85 regulatory subunit of the Phosphoinositide 3-Kinase, and the other utilizes ubiquitin-based proteasomal degradation. Truncated PFCP EpoRs are not properly down-regulated upon stimulation, underscoring the importance of these mechanisms in the pathogenesis of PFCP.

Original languageEnglish (US)
Pages (from-to)844-852
Number of pages9
JournalBritish Journal of Haematology
Volume148
Issue number6
DOIs
StatePublished - 2010

Fingerprint

Erythropoietin Receptors
Polycythemia
Erythropoietin
1-Phosphatidylinositol 4-Kinase
Ubiquitin
Hypersensitivity
Down-Regulation
Primary familial and congenital Polycythemia

Keywords

  • Endocytosis
  • Erythrocytosis
  • Erythropoietin receptor
  • Primary familial and congenital polycythemia
  • Receptor down-regulation

ASJC Scopus subject areas

  • Hematology
  • Medicine(all)

Cite this

Advances in understanding the pathogenesis of primary familial and congenital polycythaemia. / Huang, Lily J.; Shen, Yu Min; Bulut, Gamze B.

In: British Journal of Haematology, Vol. 148, No. 6, 2010, p. 844-852.

Research output: Contribution to journalArticle

@article{7e9478f726a549ab82398c84ae4ea39f,
title = "Advances in understanding the pathogenesis of primary familial and congenital polycythaemia",
abstract = "Primary familial and congenital polycythemia (PFCP) is an autosomal-dominant proliferative disorder characterized by erythrocytosis and hypersensitivity of erythroid progenitors to erythropoietin (Epo). Several lines of evidence suggest a causal role of truncated erythropoietin receptor (EpoR) in this disease. In this review, we discuss PFCP in the context of erythrocytosis and EpoR signalling. We focus on recent studies describing mechanisms underlying Epo-dependent EpoR down-regulation. One mechanism depends on internalization mediated through the p85 regulatory subunit of the Phosphoinositide 3-Kinase, and the other utilizes ubiquitin-based proteasomal degradation. Truncated PFCP EpoRs are not properly down-regulated upon stimulation, underscoring the importance of these mechanisms in the pathogenesis of PFCP.",
keywords = "Endocytosis, Erythrocytosis, Erythropoietin receptor, Primary familial and congenital polycythemia, Receptor down-regulation",
author = "Huang, {Lily J.} and Shen, {Yu Min} and Bulut, {Gamze B.}",
year = "2010",
doi = "10.1111/j.1365-2141.2009.08069.x",
language = "English (US)",
volume = "148",
pages = "844--852",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Advances in understanding the pathogenesis of primary familial and congenital polycythaemia

AU - Huang, Lily J.

AU - Shen, Yu Min

AU - Bulut, Gamze B.

PY - 2010

Y1 - 2010

N2 - Primary familial and congenital polycythemia (PFCP) is an autosomal-dominant proliferative disorder characterized by erythrocytosis and hypersensitivity of erythroid progenitors to erythropoietin (Epo). Several lines of evidence suggest a causal role of truncated erythropoietin receptor (EpoR) in this disease. In this review, we discuss PFCP in the context of erythrocytosis and EpoR signalling. We focus on recent studies describing mechanisms underlying Epo-dependent EpoR down-regulation. One mechanism depends on internalization mediated through the p85 regulatory subunit of the Phosphoinositide 3-Kinase, and the other utilizes ubiquitin-based proteasomal degradation. Truncated PFCP EpoRs are not properly down-regulated upon stimulation, underscoring the importance of these mechanisms in the pathogenesis of PFCP.

AB - Primary familial and congenital polycythemia (PFCP) is an autosomal-dominant proliferative disorder characterized by erythrocytosis and hypersensitivity of erythroid progenitors to erythropoietin (Epo). Several lines of evidence suggest a causal role of truncated erythropoietin receptor (EpoR) in this disease. In this review, we discuss PFCP in the context of erythrocytosis and EpoR signalling. We focus on recent studies describing mechanisms underlying Epo-dependent EpoR down-regulation. One mechanism depends on internalization mediated through the p85 regulatory subunit of the Phosphoinositide 3-Kinase, and the other utilizes ubiquitin-based proteasomal degradation. Truncated PFCP EpoRs are not properly down-regulated upon stimulation, underscoring the importance of these mechanisms in the pathogenesis of PFCP.

KW - Endocytosis

KW - Erythrocytosis

KW - Erythropoietin receptor

KW - Primary familial and congenital polycythemia

KW - Receptor down-regulation

UR - http://www.scopus.com/inward/record.url?scp=77649200801&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649200801&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2009.08069.x

DO - 10.1111/j.1365-2141.2009.08069.x

M3 - Article

VL - 148

SP - 844

EP - 852

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -